|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 525.19 USD | -1.46% |
|
-3.66% | +12.49% |
Projected Income Statement: HCA Healthcare, Inc.
Annual
Quarterly
Annual
Quarterly
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 58,752 | 60,233 | 64,968 | 70,603 | 75,600 | 78,685 | 82,508 | 87,144 |
| Change | - | 2.52% | 7.86% | 8.67% | 7.08% | 4.08% | 4.86% | 5.62% |
| EBITDA 1 | 12,644 | 12,067 | 12,726 | 13,882 | 15,566 | 16,019 | 16,760 | 17,727 |
| Change | - | -4.56% | 5.46% | 9.08% | 12.13% | 2.91% | 4.63% | 5.77% |
| EBIT 1 | 9,791 | 9,098 | 9,649 | 10,570 | 12,043 | 12,348 | 12,875 | 13,701 |
| Change | - | -7.08% | 6.06% | 9.55% | 13.94% | 2.53% | 4.27% | 6.42% |
| Interest Paid 1 | -1,566 | -1,741 | -1,938 | -2,061 | -2,248 | -2,403 | -2,459 | -2,484 |
| Earnings before Tax (EBT) 1 | 9,833 | 8,580 | 7,706 | 8,523 | 9,832 | 10,063 | 10,517 | 11,225 |
| Change | - | -12.74% | -10.19% | 10.6% | 15.36% | 2.35% | 4.51% | 6.73% |
| Net income 1 | 6,956 | 5,643 | 5,242 | 5,760 | 6,784 | 6,825 | 7,145 | 7,589 |
| Change | - | -18.88% | -7.11% | 9.88% | 17.78% | 0.6% | 4.69% | 6.22% |
| Announcement Date | 27/01/22 | 27/01/23 | 30/01/24 | 24/01/25 | 27/01/26 | - | - | - |
1USD in Million
Estimates
Forecast Balance Sheet: HCA Healthcare, Inc.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 33,128 | 37,176 | 38,658 | 41,098 | 45,452 | 47,334 | 45,004 | 49,904 |
| Change | - | 12.22% | 3.99% | 6.31% | 10.59% | 4.14% | -4.92% | 10.89% |
| Announcement Date | 27/01/22 | 27/01/23 | 30/01/24 | 24/01/25 | 27/01/26 | - | - | - |
1USD in Million
Estimates
Cash Flow Forecast: HCA Healthcare, Inc.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 3,577 | 4,395 | 4,744 | 4,875 | 4,944 | 5,206 | 5,421 | 5,816 |
| Change | - | 22.87% | 7.94% | 2.76% | 1.42% | 5.3% | 4.12% | 7.29% |
| Free Cash Flow (FCF) 1 | 5,382 | 4,127 | 4,687 | 5,639 | 7,692 | 7,510 | 7,833 | 7,410 |
| Change | - | -23.32% | 13.57% | 20.31% | 36.41% | -2.37% | 4.3% | -5.4% |
| Announcement Date | 27/01/22 | 27/01/23 | 30/01/24 | 24/01/25 | 27/01/26 | - | - | - |
1USD in Million
Estimates
Forecast Financial Ratios: HCA Healthcare, Inc.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
| EBITDA Margin (%) | 21.52% | 20.03% | 19.59% | 19.66% | 20.59% | 20.36% | 20.31% | 20.34% |
| EBIT Margin (%) | 16.66% | 15.1% | 14.85% | 14.97% | 15.93% | 15.69% | 15.6% | 15.72% |
| EBT Margin (%) | 16.74% | 14.24% | 11.86% | 12.07% | 13.01% | 12.79% | 12.75% | 12.88% |
| Net margin (%) | 11.84% | 9.37% | 8.07% | 8.16% | 8.97% | 8.67% | 8.66% | 8.71% |
| FCF margin (%) | 9.16% | 6.85% | 7.21% | 7.99% | 10.17% | 9.54% | 9.49% | 8.5% |
| FCF / Net Income (%) | 77.37% | 73.13% | 89.41% | 97.9% | 113.38% | 110.04% | 109.63% | 97.64% |
Profitability | ||||||||
| ROA | 14.16% | 10.94% | 9.46% | 9.95% | 11.28% | 11.08% | 11.11% | 11.2% |
| ROE | 352.48% | - | - | - | - | 9,522.46% | 85.33% | - |
Financial Health | ||||||||
| Leverage (Debt/EBITDA) | 2.62x | 3.08x | 3.04x | 2.96x | 2.92x | 2.95x | 2.69x | 2.82x |
| Debt / Free cash flow | 6.16x | 9.01x | 8.25x | 7.29x | 5.91x | 6.3x | 5.75x | 6.73x |
Capital Intensity | ||||||||
| CAPEX / Current Assets (%) | 6.09% | 7.3% | 7.3% | 6.9% | 6.54% | 6.62% | 6.57% | 6.67% |
| CAPEX / EBITDA (%) | 28.29% | 36.42% | 37.28% | 35.12% | 31.76% | 32.5% | 32.34% | 32.81% |
| CAPEX / FCF (%) | 66.46% | 106.49% | 101.22% | 86.45% | 64.27% | 69.32% | 69.2% | 78.49% |
Items per share | ||||||||
| Cash flow per share 1 | 27.25 | 28.92 | 34.12 | 40.16 | 52.76 | 53.74 | 57.21 | - |
| Change | - | 6.13% | 17.97% | 17.7% | 31.38% | 1.86% | 6.45% | - |
| Dividend per Share 1 | 1.92 | 2.24 | 2.4 | 2.64 | - | 3.038 | 3.219 | 3.553 |
| Change | - | 16.67% | 7.14% | 10% | - | - | 5.96% | 10.37% |
| Book Value Per Share 1 | -2.838 | -9.39 | -6.681 | -9.997 | - | -28.56 | -30.72 | -34.42 |
| Change | - | -230.88% | 28.85% | -49.63% | - | - | -7.56% | -12.05% |
| EPS 1 | 21.16 | 19.15 | 18.97 | 22 | 28.33 | 30.43 | 33.24 | 37.56 |
| Change | - | -9.5% | -0.94% | 15.97% | 28.77% | 7.41% | 9.22% | 13.02% |
| Nbr of stocks (in thousands) | 3,11,023 | 2,82,717 | 2,67,661 | 2,53,297 | 2,28,194 | 2,23,569 | 2,23,569 | 2,23,569 |
| Announcement Date | 27/01/22 | 27/01/23 | 30/01/24 | 24/01/25 | 27/01/26 | - | - | - |
1USD
Estimates
| 2026 * | 2027 * | |
|---|---|---|
| P/E ratio | 17.3x | 15.8x |
| PBR | -18.4x | -17.1x |
| EV / Sales | 2.09x | 1.97x |
| Yield | 0.58% | 0.61% |
EPS & Dividend
Y-o-Y evolution of P/E
Year-on-year evolution of the Yield
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
525.19USD
Average target price
543.05USD
Spread / Average Target
+3.40%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HCA Stock
- Financials HCA Healthcare, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















